ACS2016 Stephen Mulligan
Royal North Shore Hospital, NSW, Australia
- This delegate is contactable by email.
- This delegate is presenting an abstract at this event.
Abstracts this author is a contributor to:
Flow Cytometry in the Assessment of Prognosis and Novel Therapeutic Agents in Chronic Lymphocytic Leukemia (CLL). (24095)
11:59 AM
Giles Best
Immunology, Haematology and Breaking Research
Clinical use of flow cytometry for the CLL patient and implications for patient management (24094)
12:21 PM
Stephen Mulligan
Immunology, Haematology and Breaking Research